RxDoctor Payments Data

Omer Tarar, MD

Endocrinology, Diabetes & Metabolism · Henderson, NVNPI 1891161162

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,360 and has fallen 69.1% since, to $729 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in NV, where the typical reported total is $4,060.

$4,543in general payments, 2019–2025

Across 219 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$464
  • Abbott$400
  • Dexcom, Inc.$335
  • AstraZeneca$265
  • Tandem Diabetes Care, Inc.$244
  • Boehringer Ingelheim$235
  • plus $3K from 28 others

What the payments were for

  • Food & beverage$4,48899%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,543 in reported general payments places this provider in the 50th percentile of 75 endocrinology, diabetes & metabolism providers in Nevada.

See all endocrinology, diabetes & metabolism providers in Nevada

Medicare billing

Part B allowed, 2024
$385,206
Medicare patients
500
Services billed
3,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →